Document is current
Any future updates will be listed below
-
Authors
Veritti, Daniele https://orcid.org/0000-0003-0148-5348
Sarao, Valentina https://orcid.org/0000-0003-0041-5073
Martin, Asia Amelia
Bonini, Francesco
Lanzetta, Paolo https://orcid.org/0000-0003-3746-141X
- License Information
-
More Information
Article History
Received: 30 October 2025
Revised: 16 January 2026
Accepted: 10 February 2026
First Online: 25 February 2026
Competing interests
: DV is consultant for Bayer, Novartis, Roche; VS is consultant for Bayer, I-Care, Roche; AAM and FB declare no conflict of interests; PL is consultant for Aerie, Allergan, Annexon, Apellis, Bausch & Lomb, Bayer, Biogen, Boehringer Ingelheim, EyeBio, Genentech, I-Care, Novartis, Ocular Therapeutix, Outlook Therapeutics, and Roche.
